ArticleHaematologica2021

Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study.

Sabine Kayser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.